Pricing Log in Create free account

Citius Oncology, Inc. (CTOR) vs Talphera, Inc. (TLPH)

Citius Oncology, Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Citius Oncology, Inc. is the larger, with a market value of $69.4M against $55.5M — 1.2× the size. Across the 10 metrics below, Talphera, Inc. leads on 6 and Citius Oncology, Inc. on 4.

Valuation

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S n/m 191.48 2.11
P/B 2.00 5.66 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales n/m 166.32 2.73
Earnings yield (62.67%) (25.00%) (4.38%)
Free cash flow yield (39.72%) (11.83%) 0.00%

Profitability

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Gross margin — 100.00% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (126.58%) (143.36%) (0.40%)
Return on assets (45.20%) (69.60%) (3.32%)
Return on invested capital (67.15%) 0.00% 0.00%

Growth

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (73.07%) 10.01%
EPS growth (last fiscal year) (9.68%) 32.00% 49.06%
Revenue growth, 5-year CAGR — (58.55%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.05
Current ratio 0.73 4.29 2.31
Net debt to EBITDA (0.40) 1.50 0.97

Dividend

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Market cap 69.36m 55.54m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack